Gene · 8655
Papers2,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Preparing infection detection technology for hospital at home after lower limb external fixation. | Digit Health | 2022 | 35783467 | PubTator, text mining | PubMed |
| Mapping Lower-Limb Prosthesis Load Distributions Using a Low-Cost Pressure Measurement System. | Front Med Technol | 2022 | 35782578 | PubTator, text mining | PubMed |
| mRNAsi-related genes can effectively distinguish hepatocellular carcinoma into new molecular subtypes. | Comput Struct Biotechnol J | 2022 | 35765647 | PubTator, text mining | PubMed |
| Improved process intermediate stability through the identification and elimination of reactive glycation residues - a monoclonal antibody case study. | Bioengineered | 2022 | 35757891 | PubTator, text mining | PubMed |
| DNA damage-induced transcription stress triggers the genome-wide degradation of promoter-bound Pol II. | Nat Commun | 2022 | 35750669 | PubTator, text mining | PubMed |
| Single trait versus principal component based association analysis for flowering related traits in pigeonpea. | Sci Rep | 2022 | 35729192 | PubTator, text mining | PubMed |
| Autophagy Induced by Muscarinic Acetylcholine Receptor 1 Mediates Migration and Invasion Targeting Atg5 via AMPK/mTOR Pathway in Prostate Cancer. | J Oncol | 2022 | 35720225 | PubTator, text mining | PubMed |
| Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature. | Hepatol Commun | 2022 | 35712812 | PubTator, text mining | PubMed |
| The KASH5 protein involved in meiotic chromosomal movements is a novel dynein activating adaptor. | Elife | 2022 | 35703493 | PubTator, text mining | PubMed |
| Dynein light chain LC8 alleviates nonalcoholic steatohepatitis by inhibiting NF-κB signaling and reducing oxidative stress. | J Cell Physiol | 2022 | 35696549 | PubTator, text mining | PubMed |
| Insights into the Possible Molecular Mechanisms of Resistance to PARP Inhibitors. | Cancers (Basel) | 2022 | 35681784 | PubTator, text mining | PubMed |
| LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | BMC Cancer | 2022 | 35676659 | PubTator, text mining | PubMed |
| A Multiomics Profiling Based on Online Database Revealed Prognostic Biomarkers of BLCA. | Biomed Res Int | 2022 | 35669725 | PubTator, text mining | PubMed |
| The molecular mechanism and challenge of targeting XPO1 in treatment of relapsed and refractory myeloma. | Transl Oncol | 2022 | 35660848 | PubTator, text mining | PubMed |
| A genetic correlation scan identifies blood proteins associated with bone mineral density. | BMC Musculoskelet Disord | 2022 | 35659283 | PubTator, text mining | PubMed |
| Bank loan information and information asymmetry in the stock market: evidence from China. | Financ Innov | 2022 | 35646515 | PubTator, text mining | PubMed |
| A Contemporary Insight of Metabolomics Approach for Type 1 Diabetes: Potential for Novel Diagnostic Targets. | Diabetes Metab Syndr Obes | 2022 | 35642181 | PubTator, text mining | PubMed |
| Vision-Related Quality of Life and Association Between Retinal Parameters in Patients with Non-Arteritic Anterior Ischemic Optic Neuropathy. | Int J Gen Med | 2022 | 35637700 | PubTator, text mining | PubMed |
| DLEU1 promotes cell survival by preventing DYNLL1 degradation in esophageal squamous cell carcinoma. | J Transl Med | 2022 | 35619131 | PubTator, text mining | PubMed |
| Suppression of FAM83D Inhibits Glioma Proliferation, Invasion and Migration by Regulating the AKT/mTOR Signaling Pathway. | Transl Oncol | 2022 | 35617811 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8655/papers?page=19